Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alfred Akirov currently holds 4,915,383 shares of Protalix BioTherapeutics, Inc. (PLX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alfred Akirov has been a net seller of PLX stock. They have purchased $0 and sold $903.3K worth of shares.
Alfred Akirov's most recent insider trade was on Aug 15, 2013, when they sold 2,330 shares at $5.07 per share.
Alfred Akirov serves as Executive at Protalix BioTherapeutics, Inc. (PLX). They have executed 18 insider transactions totaling $903.3K over their tenure at the company.
Alfred Akirov holds the position of Executive at Protalix BioTherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Alfred Akirov has shown a selling trading pattern, with $0 in total purchases and $903.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Alfred Akirov was on Aug 14, 2013, when they sold $505.0K worth of PLX shares. This transaction involved 100,000 shares at $5.05 per share.
Alfred Akirov currently owns 4,915,383 shares of Protalix BioTherapeutics, Inc. (PLX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alfred Akirov's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alfred Akirov has 18 Form 4 filings on record as an insider at Protalix BioTherapeutics, Inc..
Set alerts for Alfred Akirov and 40,000+ other insiders.